title: Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.
authors.affiliation: Department of Infectious Diseases, Austin Hospital, Heidelberg, Victoria, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia; Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. Electronic address: jason.trubiano@austin.org.au.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Trubiano
authors.affiliation: Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
authors.forename: Alec
authors.initials: A
authors.lastname: Redwood
authors.affiliation: Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
authors.forename: Kaija
authors.initials: K
authors.lastname: Strautins
authors.affiliation: Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Pavlos
authors.affiliation: Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Emily
authors.initials: E
authors.lastname: Woolnough
authors.affiliation: Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Christina C
authors.initials: CC
authors.lastname: Chang
authors.affiliation: Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Department of Pharmacology, Oates Institute for Experimental Therapeutics, Vanderbilt University Medical School, Nashville, Tenn.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Phillips
mesh_terms: D000328:Adult; D000485:Allergens / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000276:immunology / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D057915:Drug Substitution; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis* / Q000628:therapy; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9 / Q000378:metabolism*; D015854:Up-Regulation; D033921:Vesicular Transport Proteins; D055815:Young Adult
chemical_list: D000485:Allergens; D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; C119248:LYVE1 protein, human; D013256:Steroids; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9; D033921:Vesicular Transport Proteins